AT275737B - Verfahren zur Herstellung von stabilisierten pharmazeutischen Lösungen von α-Liponsäure - Google Patents
Verfahren zur Herstellung von stabilisierten pharmazeutischen Lösungen von α-LiponsäureInfo
- Publication number
- AT275737B AT275737B AT1145467A AT1145467A AT275737B AT 275737 B AT275737 B AT 275737B AT 1145467 A AT1145467 A AT 1145467A AT 1145467 A AT1145467 A AT 1145467A AT 275737 B AT275737 B AT 275737B
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- lipoic acid
- pharmaceutical solutions
- stabilized pharmaceutical
- stabilized
- Prior art date
Links
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 title 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 title 1
- 235000019136 lipoic acid Nutrition 0.000 title 1
- 239000003186 pharmaceutical solution Substances 0.000 title 1
- 229960002663 thioctic acid Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1617740 | 1967-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT275737B true AT275737B (de) | 1969-11-10 |
Family
ID=5682288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT1145467A AT275737B (de) | 1967-09-25 | 1967-12-19 | Verfahren zur Herstellung von stabilisierten pharmazeutischen Lösungen von α-Liponsäure |
Country Status (4)
| Country | Link |
|---|---|
| AT (1) | AT275737B (de) |
| DE (1) | DE1617740B1 (de) |
| ES (1) | ES357954A1 (de) |
| FR (1) | FR1605097A (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3867445D1 (de) * | 1987-12-04 | 1992-02-13 | Asta Pharma Ag | Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren. |
| DK173585B1 (da) * | 1989-11-09 | 2001-04-02 | Asta Medica Ag | Anvendelse af alfa-liponsyre til fremstilling af et lægemiddel til bekæmpelse af sygdomme fremkaldt af retrovirus |
| DE102004050353A1 (de) * | 2004-10-15 | 2006-04-20 | Basf Ag | Verwendung stabiler Ammoniumsalze der Liponsäure zur Behandlung diabetischer und weiterer Störungen |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1205972B (de) * | 1963-08-20 | 1965-12-02 | Merck Ag E | Verfahren zur Herstellung eines Liponsaeure-derivates |
-
1967
- 1967-09-25 DE DE1967P0043060 patent/DE1617740B1/de not_active Withdrawn
- 1967-12-19 AT AT1145467A patent/AT275737B/de active
-
1968
- 1968-09-09 ES ES357954A patent/ES357954A1/es not_active Expired
- 1968-09-18 FR FR1605097D patent/FR1605097A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES357954A1 (es) | 1970-04-01 |
| DE1617740B1 (de) | 1971-11-04 |
| FR1605097A (en) | 1973-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH518951A (de) | Verfahren zur Herstellung von 2-Amino-adenosinderivaten | |
| CH507248A (de) | Verfahren zur Herstellung von D-6-Methylergolin(I)ylessigsäure | |
| AT286314B (de) | Verfahren zur Herstellung von 2,2-Dichlor-vinyl-phosphorsäureesteramiden | |
| CH498104A (de) | Verfahren zur Herstellung von Carbamidsäurefluoriden | |
| CH526538A (de) | Verfahren zur Herstellung von Aminophenylessigsäure-Derivaten | |
| CH505854A (de) | Verfahren zur Herstellung von pharmazeutisch wirksamen Verbindungen der 7-Acylamino-Cephalosporansäure | |
| CH517690A (de) | Verfahren zur Herstellung von a-Methyl-2-naphthyl-essigsäurealkylestern | |
| CH504473A (de) | Verfahren zur Herstellung von Cephalosporansäurederivaten | |
| CH496010A (de) | Verfahren zur Herstellung von d-Lysergsäureamiden | |
| CH492669A (de) | Verfahren zur Herstellung von p-Hydroxybenzoesäure | |
| CH501601A (de) | Verfahren zur Herstellung von 4,4'-Diphenyldisulfonsäure | |
| AT275737B (de) | Verfahren zur Herstellung von stabilisierten pharmazeutischen Lösungen von α-Liponsäure | |
| CH500935A (de) | Verfahren zur Herstellung von Phenylsalicylsäure-Verbindungen | |
| AT299447B (de) | Verfahren zur Herstellung von 7-Aminocephalosporansäure | |
| CH500232A (de) | Verfahren zur Herstellung von Alkylthionophosphonsäuredichloriden | |
| AT292014B (de) | Verfahren zur Herstellung von Organozinnmerkaptosäureestern | |
| AT284143B (de) | Verfahren zur Herstellung von neuen Dithiocarbaminsäurederivaten | |
| CH499483A (de) | Verfahren zur Herstellung von Phenoxyphthalsäureester | |
| CH508589A (de) | Verfahren zur Herstellung von B-Aminocarbonsäurederivaten | |
| CH510059A (de) | Verfahren zur Herstellung von Amidothionophosphorsäurephenylestern | |
| AT286960B (de) | Verfahren zur Herstellung der d-trans-Pyrethrinsäure | |
| CH501555A (de) | Verfahren zur Herstellung von Hydroxylamin-O-sulfosäure | |
| CH485641A (de) | Verfahren zur Herstellung von Acetessigsäureestern | |
| CH497395A (de) | Verfahren zur Herstellung von Sulfensäurederivaten | |
| CH481927A (de) | Verfahren zur Herstellung von 2,4-Dichlor-pyrimidin-5-carbonsäurechlorid |